XETRA - Delayed Quote EUR

Biofrontera AG (B8FK.DE)

Compare
2.2700
0.0000
(0.00%)
At close: January 10 at 5:36:26 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,174.0000
32,249.0000
25,738.0000
28,787.0000
30,346.0000
Cost of Revenue
4,851.0000
6,243.0000
4,757.0000
3,913.0000
3,536.0000
Gross Profit
13,323.0000
26,005.0000
20,981.0000
24,873.0000
26,810.0000
Operating Expense
18,216.0000
21,224.0000
19,390.0000
60,213.0000
34,421.0000
Operating Income
-4,893.0000
4,781.0000
1,591.0000
-35,340.0000
-7,611.0000
Net Non Operating Interest Income Expense
26.0000
6.0000
-162.0000
-3,707.0000
-2,669.0000
Other Income Expense
--
--
--
--
-2,419.0000
Pretax Income
-3,777.0000
-2,127.0000
-43,210.0000
35,683.0000
-12,697.0000
Tax Provision
-3,420.0000
-1,758.0000
956.0000
2,397.0000
326.0000
Net Income Common Stockholders
-357.0000
-369.0000
-44,166.0000
37,747.0000
-13,023.0000
Diluted NI Available to Com Stockholders
-357.0000
-369.0000
-44,166.0000
37,747.0000
-13,023.0000
Basic EPS
0.83
-0.21
-16.17
13.66
-4.82
Diluted EPS
0.83
-0.21
-16.17
13.46
-4.82
Basic Average Shares
6,076.8620
3,038.4310
2,736.9000
2,757.1880
2,696.9250
Diluted Average Shares
6,076.8620
3,038.4310
2,736.9000
2,823.2450
2,696.9250
Total Operating Income as Reported
-4,892.0000
4,782.0000
1,591.0000
-35,341.0000
-7,611.0000
Total Expenses
23,067.0000
27,467.0000
24,147.0000
64,126.0000
37,957.0000
Net Income from Continuing & Discontinued Operation
-357.0000
-369.0000
-44,166.0000
37,747.0000
-13,023.0000
Normalized Income
-357.0000
-369.0000
-44,166.0000
37,747.0000
-13,023.0000
Interest Income
37.0000
21.0000
1.0000
13.0000
411.0000
Interest Expense
11.0000
15.0000
163.0000
3,720.0000
3,080.0000
Net Interest Income
26.0000
6.0000
-162.0000
-3,707.0000
-2,669.0000
EBIT
-3,766.0000
-2,112.0000
-43,047.0000
39,403.0000
-9,617.0000
EBITDA
-3,766.0000
-1,321.0000
-42,301.0000
42,693.0000
-4,284.0000
Reconciled Cost of Revenue
4,851.0000
6,243.0000
4,757.0000
3,913.0000
3,536.0000
Reconciled Depreciation
--
791.0000
746.0000
3,290.0000
5,333.0000
Net Income from Continuing Operation Net Minority Interest
-357.0000
-369.0000
-44,166.0000
37,747.0000
-13,023.0000
Normalized EBITDA
-3,766.0000
-1,321.0000
-42,301.0000
42,693.0000
-4,284.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0001
0.0003
12/31/2020 - 10/31/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

H6D0.DE Haleon plc
4.4650
-3.12%
 
HIGH.DE Cantourage Group SE
4.8200
0.00%
 
ZOE.DE Zoetis Inc.
160.64
+0.59%
 
27N0.DE CANNOVUM CANNABIS AG I
0.5300
+0.95%
 
BXT.DE BioNxt Solutions Inc.
0.2630
-3.66%
 
VIA.DE Viatris Inc.
11.36
-1.65%
 
APPH.DE Apontis Pharma AG
10.20
+0.99%
 
PSG.DE PharmaSGP Holding SE
26.80
+0.75%
 
2HQ.DE Tilray Brands, Inc.
1.1715
-10.26%
 
DMP.DE Dermapharm Holding SE
40.05
+0.63%